Breast cancer with synchronous metastases: trends in survival during a 14-year period.
暂无分享,去创建一个
R. Rouzier | M. Namer | F. André | H. Marsiglia | M. Spielmann | S. Delaloge | T. Bachelot | J. Spano | K. Slimane | A. Dunant | Alain Barrelier | O. Kabbaj
[1] J. Ragaz,et al. Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] U. Chetty,et al. Does local surgery have a role in the management of stage IV breast cancer? , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[3] Jenny C. Chang,et al. Survival of patients with metastatic breast carcinoma , 2003, Cancer.
[4] M. Piccart,et al. Chemotherapy for metastatic breast cancer-report of a European expert panel. , 2002, The Lancet. Oncology.
[5] Daniel Levy,et al. Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.
[6] G. Mundy. Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.
[7] David Miles,et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] T. Fleming,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.
[9] J. Jassem,et al. Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J. Armitage,et al. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Healey,et al. Orthopedic emergencies in cancer patients. , 2000, Seminars in Oncology.
[12] L. Dirix,et al. Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] G. D'aiuto,et al. Changing patterns of breast cancer stage at diagnosis in southern italy: hospital data as indicators of progressive changes. , 2000, Preventive medicine.
[14] D. Richel,et al. Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy , 1999 .
[15] G. Sledge,et al. The role of chemotherapy for metastatic breast cancer. , 1999, Hematology/oncology clinics of North America.
[16] Anthony Howell,et al. Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma , 1998, Cancer.
[17] P. Dombernowsky,et al. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] D. Górecka,et al. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. , 1997, Thorax.
[19] J. Rossi,et al. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma , 1996 .
[20] L. Hutchins,et al. Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] L. Norton,et al. Metastatic breast cancer. Length and quality of life. , 1991, The New England journal of medicine.
[22] C. Spurr,et al. Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association. , 1991, The New England journal of medicine.
[23] L. Sobin,et al. TNM classification of malignant tumors. A comparison between the new (1987) and the old editions , 1988, Cancer.